Reassessing the Link: Depression and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: Insights From the ACCORD‐HRQL Study
Depression and Anxiety · 2025
DOI: 10.1155/da/1885956 ↗Kurz gefasst
Fachartikel in der Zeitschrift Depression and Anxiety, 2025. Verfasst von Dingwu Yi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Extracorporeal Life Support Center of Cardiovascular Surgery, Second Xiangya Hospital, Central South University, Chang…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies, Depression, Quality of Life. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus, Depression
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) patients with depression are often accompanied by diabetic nephropathy. However, limited prospective studies have investigated the independent association between depression and diabetic nephropathy, as well as its progression among T2DM patients. This study aims to investigate the association between depression and the development or progression of diabetic nephropathy in T2DM patients, utilizing data from the ACCORD Health‐Related Quality of Life (HRQL) study. Methods and Results: The nine‐item Patient Health Questionnaire (PHQ‐9) was utilized to assess depressive symptoms at baseline, and at 1, 3, and 4 years. The primary outcomes included deterioration of renal function, macroalbuminuria, and microalbuminuria. The changes in renal function were evaluated using estimated glomerular filtration rate (eGFR). As the severity of depression, measured by the PHQ‐9, increased, there was no corresponding rise in the risk of deterioration in renal function (HR, 1.00; 95% CI, 0.98–1.01), macroalbuminuria (HR, 0.99; 95% CI, 0.53–1.86), or microalbuminuria (HR, 1.00; 95% CI, 0.97–1.03) per unit increase in PHQ‐9 score. The estimated unadjusted eGFR (mL/min/1.73 m 2 ) decline over the entire study period did not significantly differ for each 1‐year increase in age (none: 2.21, 95% CI 1.98–2.44; ever depression: 2.51, 95% CI 2.36–2.67; persist depression: 2.28, 95% CI 1.99–2.57; all pairwise p ‐values > 0.05).
Conclusions
T2DM patients with depression do not demonstrate lower renal function or an increased rate of renal function decline. Moreover, they do not exhibit a heightened risk of renal function deterioration, macroalbuminuria, or microalbuminuria compared to T2DM patients without depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Extracorporeal Life Support Center of Cardiovascular Surgery, Second Xiangya Hospital, Central South University, Changsha, China.
- Department of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China.
- Emergency Medicine and Difficult Diseases Institute, Central South University, Changsha 410011, China.
ORCID-Profile: Dingwu Yi, Zhenhua Xing
Zitieren
APA
Yi, D., & Xing, Z. (2025). Reassessing the Link: Depression and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: Insights From the ACCORD‐HRQL Study. Depression and Anxiety. https://doi.org/10.1155/da/1885956
Vancouver
Yi D, Xing Z. Reassessing the Link: Depression and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: Insights From the ACCORD‐HRQL Study. Depression and Anxiety. 2025. doi:10.1155/da/1885956
BibTeX
@article{Yi2025,
author = {Yi, Dingwu and Xing, Zhenhua},
title = {Reassessing the Link: Depression and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: Insights From the ACCORD‐HRQL Study},
journal = {Depression and Anxiety},
year = {2025},
doi = {10.1155/da/1885956}
}
EUVIMED